Antituberculosis agents VIII: Synthesis and in vitro antimycobacterial activity of alkyl α-[5-(5-nitro-2-thienyl)-1,3,4-thiadiazole-2-ylthio] acetates

Farmaco

Volumn 58, Issue 11, 2003, Pages 1073-1076

  Foroumadi, Alireza ^a   Kiani, Zahra ^a   Soltani, Fatemeh ^a  

^a KERMAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

1,3,4 Thiadiazole; 5 Nitrothiophene; Antituberculosis agents; Minimum inhibitory concentration

Indexed keywords

ACETIC ACID DERIVATIVE; BUTYL ALPHA [5 (5 NITRO 2 THIENYL) 1,3,4 THIADIAZOL 2 YLTHIO]ACETATE; ETHYL ALPHA [5 (5 NITRO 2 THIENYL) 1,3,4 THIADIAZOL 2 YLTHIO]ACETATE; METHYL ALPHA [5 (5 NITRO 2 THIENYL) 1,3,4 THIADIAZOL 2 YLTHIO]ACETATE; PHENYLMETHYL ALPHA [5 (5 NITRO 2 THIENYL) 1,3,4 THIADIAZOL 2 YLTHIO]ACETATE; PROPYL ALPHA [5 (5 NITRO 2 THIENYL) 1,3,4 THIADIAZOL 2 YLTHIO]ACETATE; THIADIAZOLE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; DRUG SCREENING; DRUG SYNTHESIS; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; RADIOMETRY;

EID: 0142186841     PISSN: 0014827X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-827X(03)00158-7     Document Type: Article

References (11)

1. Iseman M.D. Tuberculosis. Goldman L., Bennett J.C. Cecil Textbook of Medicine. 2000;1723-1731 W.B. Saunders Company, London.
2. Grange J.M., Zulma A. The global emergency of tuberculosis: what is the cause? J. R. Soc. Health. 122:2002;78-81.
3. Culliton B.J. Drug-resistant TB may bring epidemic. Nature (London). 356:1992;472-473.
4. Foroumadi A., Mirzaei M., Shafiee A. Antituberculosis agents I. Synthesis and antituberculosis activity of 2-aryl-1,3,4-thiadiazole derivatives. Pharmazie. 56:2001;610-612.
5. Savornin B., Madadi N.E., Delmas F., Gasquet M., Timon-David P., Vanelle P., Maldonado J. Evaluation of in vitro leshmanicidal activity of hydrazones of thiophene carboxaldehydes against promastigotes of Leishmania infantum an Leishmania tropica. J. Pharm. Pharmacol. 43:1991;58-59.
6. Tedlaouti F., Gasquet M., Delmas F., Timon-David P., Maddadi N.E., Vanelle P., Maldonado J. Evaluation of the antimalaria activity of new compounds against Plasmodium falciparum, in vitro and Plasmodium berghei in vivo. J. Pharm. Belg. 45:1990;306-310.
7. Cerecetto H., Di Maio R., Ibarruri G., Seoane G., Denicola A., Pluffo G., Quijano C., Paulino M. Synthesis and anti-trypanosomal activity of novel 5-nitro-2-furaldehyde and 5-nitrothiophene-2-carboxaldehyde semicarbazone derivatives. Farmaco. 53:1998;89-94.
8. Ronsisvalle G., Blandino G. Synthesis, spectra behaviour and microbiological properties of some di(nitrothienyl)sulfides. Farmaco [Sci]. 36:1981;785-793.
9. Rando D.G., Sato D.N., Siqueira L., Malvezzi A., Leite C.Q., Amaral A.T., Ferreira E.I., Tavares L.C. Potential tuberculostatic agents. Topliss application on benzoic acid[(5-nitro thiophen-2-yl)-methylene]-hydrazide series. Bioorg. Med. Chem. 10:2002;557-560.
10. Combes G. A new method of preparing 2-thenaldehyde(2-thiophenecarbox- aldehyde) -formation of 5-nitro-2-thenaldehyde. Bull. Soc. Chim. France. 1952;701-702.
11. Collins L., Franzblau S.G. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium. Antimicrob. Agents Chemother. 41:1997;1004-1009.